Cargando…

Latent Dirichlet Allocation in predicting clinical trial terminations

BACKGROUND: This study used natural language processing (NLP) and machine learning (ML) techniques to identify reliable patterns from within research narrative documents to distinguish studies that complete successfully, from the ones that terminate. Recent research findings have reported that at le...

Descripción completa

Detalles Bibliográficos
Autores principales: Geletta, Simon, Follett, Lendie, Laugerman, Marcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882341/
https://www.ncbi.nlm.nih.gov/pubmed/31775737
http://dx.doi.org/10.1186/s12911-019-0973-y
_version_ 1783474137080004608
author Geletta, Simon
Follett, Lendie
Laugerman, Marcia
author_facet Geletta, Simon
Follett, Lendie
Laugerman, Marcia
author_sort Geletta, Simon
collection PubMed
description BACKGROUND: This study used natural language processing (NLP) and machine learning (ML) techniques to identify reliable patterns from within research narrative documents to distinguish studies that complete successfully, from the ones that terminate. Recent research findings have reported that at least 10 % of all studies that are funded by major research funding agencies terminate without yielding useful results. Since it is well-known that scientific studies that receive funding from major funding agencies are carefully planned, and rigorously vetted through the peer-review process, it was somewhat daunting to us that study-terminations are this prevalent. Moreover, our review of the literature about study terminations suggested that the reasons for study terminations are not well understood. We therefore aimed to address that knowledge gap, by seeking to identify the factors that contribute to study failures. METHOD: We used data from the clinicialTrials.gov repository, from which we extracted both structured data (study characteristics), and unstructured data (the narrative description of the studies). We applied natural language processing techniques to the unstructured data to quantify the risk of termination by identifying distinctive topics that are more frequently associated with trials that are terminated and trials that are completed. We used the Latent Dirichlet Allocation (LDA) technique to derive 25 “topics” with corresponding sets of probabilities, which we then used to predict study-termination by utilizing random forest modeling. We fit two distinct models – one using only structured data as predictors and another model with both structured data and the 25 text topics derived from the unstructured data. RESULTS: In this paper, we demonstrate the interpretive and predictive value of LDA as it relates to predicting clinical trial failure. The results also demonstrate that the combined modeling approach yields robust predictive probabilities in terms of both sensitivity and specificity, relative to a model that utilizes the structured data alone. CONCLUSIONS: Our study demonstrated that the use of topic modeling using LDA significantly raises the utility of unstructured data in better predicating the completion vs. termination of studies. This study sets the direction for future research to evaluate the viability of the designs of health studies.
format Online
Article
Text
id pubmed-6882341
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68823412019-12-03 Latent Dirichlet Allocation in predicting clinical trial terminations Geletta, Simon Follett, Lendie Laugerman, Marcia BMC Med Inform Decis Mak Research Article BACKGROUND: This study used natural language processing (NLP) and machine learning (ML) techniques to identify reliable patterns from within research narrative documents to distinguish studies that complete successfully, from the ones that terminate. Recent research findings have reported that at least 10 % of all studies that are funded by major research funding agencies terminate without yielding useful results. Since it is well-known that scientific studies that receive funding from major funding agencies are carefully planned, and rigorously vetted through the peer-review process, it was somewhat daunting to us that study-terminations are this prevalent. Moreover, our review of the literature about study terminations suggested that the reasons for study terminations are not well understood. We therefore aimed to address that knowledge gap, by seeking to identify the factors that contribute to study failures. METHOD: We used data from the clinicialTrials.gov repository, from which we extracted both structured data (study characteristics), and unstructured data (the narrative description of the studies). We applied natural language processing techniques to the unstructured data to quantify the risk of termination by identifying distinctive topics that are more frequently associated with trials that are terminated and trials that are completed. We used the Latent Dirichlet Allocation (LDA) technique to derive 25 “topics” with corresponding sets of probabilities, which we then used to predict study-termination by utilizing random forest modeling. We fit two distinct models – one using only structured data as predictors and another model with both structured data and the 25 text topics derived from the unstructured data. RESULTS: In this paper, we demonstrate the interpretive and predictive value of LDA as it relates to predicting clinical trial failure. The results also demonstrate that the combined modeling approach yields robust predictive probabilities in terms of both sensitivity and specificity, relative to a model that utilizes the structured data alone. CONCLUSIONS: Our study demonstrated that the use of topic modeling using LDA significantly raises the utility of unstructured data in better predicating the completion vs. termination of studies. This study sets the direction for future research to evaluate the viability of the designs of health studies. BioMed Central 2019-11-27 /pmc/articles/PMC6882341/ /pubmed/31775737 http://dx.doi.org/10.1186/s12911-019-0973-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Geletta, Simon
Follett, Lendie
Laugerman, Marcia
Latent Dirichlet Allocation in predicting clinical trial terminations
title Latent Dirichlet Allocation in predicting clinical trial terminations
title_full Latent Dirichlet Allocation in predicting clinical trial terminations
title_fullStr Latent Dirichlet Allocation in predicting clinical trial terminations
title_full_unstemmed Latent Dirichlet Allocation in predicting clinical trial terminations
title_short Latent Dirichlet Allocation in predicting clinical trial terminations
title_sort latent dirichlet allocation in predicting clinical trial terminations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882341/
https://www.ncbi.nlm.nih.gov/pubmed/31775737
http://dx.doi.org/10.1186/s12911-019-0973-y
work_keys_str_mv AT gelettasimon latentdirichletallocationinpredictingclinicaltrialterminations
AT follettlendie latentdirichletallocationinpredictingclinicaltrialterminations
AT laugermanmarcia latentdirichletallocationinpredictingclinicaltrialterminations